Skip to content
RDL
Network
Ekosistem
Uygulama değiştir
EN
Hakkımızda
SSS
Giriş yap
Başla
Effect of acyclovir, bromovinyldeoxyuridine, vidarabine, and l-lysine on latent ganglionic herpes simplex virus in vitro — No-Hee Park (1982) | RDL Network
Back
Cite
Save
Save for later
Share
Home
Publications
Effect of acyclovir, bromovinyldeoxyuridine, vidarabine, and l-lysine on latent ganglionic herpes simplex virus in vitro
Shared by
De Clercq Erik
KU Leuven
Effect of acyclovir, bromovinyldeoxyuridine, vidarabine, and l-lysine on latent ganglionic herpes simplex virus in vitro
Article
1982
en
Authors
NP
No-Hee Park
DP
Deborah Pavan‐Langston
De Clercq Erik
KU Leuven
Discussion
(0)
Sign in
to like and join the discussion.
No comments yet. Be the first to comment.
Related publications
Article
1981
Effects of Oral Treatment with Acyclovir and Bromovinyldeoxyuridine on the Establishment and Maintenance of Latent Herpes Simplex Virus Infection in Mice
H. J. Field
,
De Clercq Erik
Article
1987
Combined antiviral effects of acyclovir or bromovinyldeoxyuridine and human immunoglobulin in herpes simplex virus-infected mice
J. Hilfenhaus
,
De Clercq Erik
,
R. Köhler
,
R. G. Geursen
,
F. R. Seiler
Article
1984
In vitro effect of (E)-5-(2-bromovinyl)-2′-deoxyuridine, 5′-amino-5-iodo-2′,5′-dideoxyuridine and 2-deoxy-d-glucose on latent ganglionic herpes simplex virus infection
Deborah Pavan‐Langston
,
No-Hee Park
,
De Clercq Erik
Article
1989
In vitro susceptibility of feline herpesvirus-1 to vidarabine, idoxuridine, trifluridine, acyclovir, or bromovinyldeoxyuridine
Mark P. Nasisse
,
James S. Guy
,
Michael G. Davidson
,
Wendy Sussman
,
De Clercq Erik
Article
1986
Prolonged herpes simplex virus latency in vitro after treatment of infected cells with acyclovir and human leukocyte interferon
Adrienne C. Scheck
,
B Wigdahl
,
De Clercq Erik
,
Fred Rapp
Discussion(0)
No comments yet. Be the first to comment.